Dr Mike Richardson

Ph.D (ANU, Australia)

Dr. Richardson has worked in the Biotechnology/Health Care Industry for more than 30 years. After finishing a Postdoctoral Fellowship at the Roche Institute of Molecular Biology (Nutley, New Jersey) Dr. Richardson spent 2 years at the Nippon Roche Research Center (Kamakurra, Japan) before joining Biotech Australia in Sydney, Australia. In his role at Biotech Australia Dr. Richardson engineered bacterial, yeast, insect and mammalian cell systems to produce recombinant and non-recombinant proteins for ‘in-vitro’, animal and human trials of potential therapeutic treatments.

As Director of Science at Isolagen Australia Dr. Richardson was involved in the production, QC, QA, and release for sale of a TGA licensed product (under the TGA cGMP code for ‘Human Blood and Tissue).

At NuSep (Sydney, Australia), Dr. Richardson developed In vitro diagnostic (IVD) reagents (for the detection of Lupus and von Willebrand diseases) for sale in the Australian market. Later, as Operations Manager, he was responsible for the production of pre-cast polyacrylamide gels sold worldwide.